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Abstract
Introduction: We investigated whether combining the peripheral perfusion index (PI) and central venous oxygen
saturation(ScvO2) would identify subsets of patients for assessing the tissue perfusion and predicting outcome
during the resuscitation in critically ill patients.
Methods: A total of 202 patients with central venous catheters for resuscitation were enrolled in this prospective
observational study. The arterial, central venous blood gas and the PI were measured simultaneously at the
enrollment (T0) and 8 h (T8) after early resuscitation. Based on the distribution of the PI in healthy population, a
cutoff of PI ≥1.4 was defined as a normal PI. Moreover, the critical value of PI was defined as the best cutoff value
related to the mortality in the study population. The PI impairment stratification is defined as follows: a normal
PI(≥1.4), mild PI impairment (critical value < PI < 1.4) and critical PI impairment (PI ≤ critical value).
Results: The PI at T8 was with the greatest AUC for prediction the 30-day mortality and PI is an independent
risk factor for 30-day mortality. Moreover, a cutoff of PI < 0.6 is related to poor outcomes following resuscitation.
So, based on cutoffs of ScvO2 (70 %) and critical PI (0.6) at T8, we assigned the patients to four categories: group 1
(PI ≤ 0.6 on ScvO2 < 70 %), group 2 (PI ≤ 0.6 on ScvO2≥ 70 %), group 3 (PI > 0.6 on ScvO2 < 70 %), and group 4
(PI > 0.6 on ScvO2 ≥ 70 %). The combination of low ScvO2(<70 %) and PI(≤0.6) was associated with the lowest
survival rates at 30 days [log rank (Mantel–Cox) = 87.518, p < 0.0001]. The sub-group patients who had high
ScvO2(>80 %) at T8 were with low mortality and high PI. Moreover, the normal PI (≥1.4) did not show a better
outcome than mild impaired PI (0.6-1.4) patients who had a normalized ScvO2(>70 %) after resuscitation.
The PI was correlated with the lactate, P(v-a)CO2, and ScvO2 in all the measurements (n = 404). These relationships
are strengthened with abnormal PI (PI < 1.4) but not with normal PI (PI≥ 1.4).
Conclusion: Complementing ScvO2 assessment with PI can better identify endpoints of resuscitation and adverse
outcomes. Pursuing a normalized PI (≥1.4) may not result in better outcomes for a mild impaired PI after ScvO2 is
normalized.
Introduction
Global oxygen metabolism perfusion measurements that
are derived from blood gas analysis and peripheral circu-
lation perfusion assessment are frequently used practical
methods to determine tissue perfusion. Central venous
oxygen saturation (ScvO2) has been widely accepted as
an indicator to reflect the balance between global oxygen
demand and oxygen supply, and a cutoff of 70 % for
ScvO2 has become an endpoint of early resuscitation [1].
However, recent negative results from early goal-directed
therapeutic studies have questioned whether ScvO2 equal
to or greater than 70 % should be the goal of early resusci-
tation [2, 3]. Conversely, pursuing normalization of ScvO2
may result in adverse effects. It is challenging to determine
the most appropriate criteria to stop resuscitation oppor-
tunely so as to avoid the risk of over-resuscitation. Moore
et al. suggested that the concept of early goal-directed
therapy should be revised, and the inclusion of the
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restoration of peripheral circulation perfusion in the early
resuscitation would be meaningful [4].
With the development of medical techniques, quanti-
tative assessment of peripheral tissue perfusion has be-
come prevalent in clinical practice [5–7]. Studies have
shown that persistent impairment in peripheral circula-
tion perfusion is related to a poor outcome in critically
ill patients [8, 9]. Inconsistencies in systemic oxygen me-
tabolism variables and peripheral circulation perfusion
have been investigated quite intensively in recent years
[10]. The change in finger peripheral perfusion index
(PI) results from the blood volume pulsations, the dis-
pensability of the vascular wall and the intravascular
pulse pressure [11]. It has been suggested as a reliable
and early indicator of the success of regional block, and
is known to increase due to the effect of autonomic
blockade during spinal anesthesia [12]. The PI has been
shown to reflect changes in peripheral circulation perfu-
sion and central hypovolemia, which is derived from the
photoelectric plethysmographic pulse oximetry signal
[13, 14]. Compared with the distribution of the PI in a
healthy adult population, a cutoff of PI <1.4 is used as a
very sensitive point for identifying abnormal peripheral
perfusion associated with vasoconstriction in critically ill
patients [14]. Some studies have used abnormal PI <1.4
as a potential trigger to start treatment. However, the
question as to whether an abnormal PI value <1.4 re-
quires total correction is undetermined.
The sacrifice of peripheral tissue is a self-protecting
mechanism for the vital organs during shock. It is as-
sumed that peripheral tissue is the first tissue bed to be
sacrificed during shock and the last to be re-perfused in
resuscitation. Therefore, we speculated that there would
be a critical PI value related to mortality, which works as
the safe limit. Thus, we hypothesized that the combination
of ScvO2 (to determine whether the oxygen supply is suffi-
cient or insufficient) and PI (to determine the severity of
peripheral perfusion: normal, mild impairment, critical
impairment) would provide additional information for
predicting outcomes and endpoints of resuscitation.
The aims of the study were the following: 1) to define
a critical value of PI related to mortality after resuscita-
tion in critically ill patients; 2) to define a prognostic
value of the preset clinical classification according to the
normal ScvO2 (70 %) and critical value of PI after resus-
citation; and 3) to define a prognostic value based on the




The Institutional Research and Ethics Committee of the
Peking Union Medical College Hospital approved this
study for human subjects. Written informed consent
was obtained from all patients or next of kin before data
were included in the study. When the research team was
available, adult patients within 24 h after the onset of
suspected clinical tissue hypoperfusion who were se-
quentially admitted to the Department of Critical Care
Medicine and required central venous catheters for re-
suscitation were eligible for the study. The placement of
a central venous catheter for resuscitation was deter-
mined by the attending physician according to the clin-
ical situation. Patients were excluded from the study if
they were pregnant, aged <18 years, were not expected
to survive, were brain dead, or had made a decision to
withhold or withdraw treatment. The inclusion time
(T0) and the study enrollment were considered to begin
the moment the central venous pressure monitoring
began after ICU admission.
The tissue hypoperfusion diagnostic criteria were the
following: 1) SBP ≤90 mmHg (or a decrease in SBP
≥20 % from baseline); 2) urinary output <0.5 ml/kg/min
for more than 2 h; 3) increase in heart rate (HR) ≥10 %
from baseline; 4) presence of skin mottling; and 5)
hyperlactatemia (>2 mmol/L). If one or more of these
criteria were met, clinical tissue hypoperfusion was diag-
nosed. The physician would make a decision to begin
resuscitation based on the clinical situation. Septic shock
was defined as severe sepsis with sepsis-induced hypoten-
sion persisting despite adequate fluid resuscitation and re-
quiring the administration of vasopressors [15].
All the patients received a local hemodynamic support
algorithm for critically ill patients. The early goals of
hemodynamic support are the following: central ven-
ous pressure of 8–12 mmHg; mean arterial pressure
>65 mmHg; urine output >0.5 ml/kg of body weight
(except in the patients with acute renal failure); and
ScvO2 of 70 % or more with veno-arterial CO2 tension dif-
ference (P(v-a)CO2) of 6 mmHg or less. The intensivists
were blinded to the results of the PI.
Measurements
Information collected at enrollment included demo-
graphic characteristics, such as age, sex, acute physiology
and chronic health evaluation II score (APACHE II)
[16]; global hemodynamic, arterial and central venous
blood gas analysis and PI were obtained simultaneously
at T0 and T8 (approximately 8 h (+/−1 h) after early re-
suscitation was deemed to meet the requirements).
A central venous catheter was inserted via the jugular
or the subclavian vein, and the position of the tip of the
venous catheter was in the upper part of the right atrium
verified by chest radiograph. Blood gas samples were
taken anaerobically in 3-ml heparinized syringes and an-
alyzed on a bedside blood gas machine (GEM Premier
3000, model 5700, Lexington, MA, USA or ABL90, Radi-
ometer, Copenhagen, Denmark), and the same blood gas
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machine was used to measure both the arterial and cen-
tral venous blood gas. PI was measured in the finger by
using the IntelliVue MP70 monitor (Philips Medical
Systems, Boblingen, Germany). The MP70 system cal-
culates the PI as the ratio between the pulsatile com-
ponent and the non-pulsatile component of the light
reaching the light-sensitive cell of the pulse oximetry
probe. The ambient temperature of the room was
consistent at approximately 23 to 25 °C (climate con-
trolled). Survival was defined as being alive for 30 days
after enrollment.
Study definitions
 Normal ScvO2 was defined as ≥70 %, and normal PI
was defined as ≥1.4
 The critical value of PI was derived from the best
cutoff value related to the mortality in the study
population
 The patients were divided into four categories based
on the normal ScvO2 and critical PI value
 PI impairment stratification was as follows: normal
PI (≥1.4), mild PI impairment (critical value < PI
<1.4) and critical PI impairment (PI ≤ critical value,
which was defined as mentioned above).
Statistical analysis
Descriptive analysis was performed. All data are expressed
as the mean ± standard deviation or median (25th–75th
percentiles) unless otherwise specified. For the continuous
variables, data were analyzed using the t test, analysis of
variance (ANOVA), Mann–Whitney test, or Kruskal–
Wallis test depending on their distribution and number of
variables. Comparisons of two continuous variables were
performed using linear regression. Variables were intro-
duced into a multivariable binary logistic regression model
if significantly associated with mortality at day 30, using
the univariate analysis when the p value was <0.2. General
demographics, hemodynamics, norepinephrine (NE) dose,
PI and blood gas parameters at T0 and T8 were used in
the model. Discrimination of values was performed using
receiver operating characteristic (ROC) analysis. Survival
curves up to day 30 were estimated using the Kaplan–
Meier method, and the log rank (Mantel–Cox) test was
used to estimate differences among the predefined groups.
Repeated measurements were analyzed using analysis of
variance or analysis of variance on ranks. The chi-squared
(χ2) test (or Fisher’s exact test when appropriate) was used
to compare discrete variables. All comparisons were two-
tailed, and p <0.05 was required to exclude the null hy-
pothesis. The statistical analysis was performed using the
SPSS 13.0 software package (SPSS Inc., Chicago, IL, USA).
The area under the ROC curve was compared using the
Hanley −McNeil test [17].
Results
During the study period (from November 2013 to February
2014), a total of 344 patients were admitted to our depart-
ment, and 202 critically ill patients were enrolled in this
study. Therefore, a total of 404 measurements were ob-
tained at T0 and T8 in the 202 patients. The mortality at
day 30 in this cohort was 28/202 (14 %), and length of
ICU stay was 6 ± 10 days. The demographics and clinical
characteristics of all the patients are shown in Table 1.
The distribution of all PI measurements was skewed, and
values ranged from 0 to 8 with a median of 1.33 and an
interquartile range of 2. The flow diagram in Fig. 1 shows
the 202 patients according to ScvO2 and PI at T8 after
resuscitation. The median time between ICU admission
and enrollment (T0) was 1 h.
Prediction of mortality at day 30
There were no differences in MAP, CVP, age, ScvO2,
PI, lactate, or difference between central venous and
arterial PCO2 (P(v-a)CO2) at baseline (T0) between the
survivors and non-survivors. In addition, statistically
significant variables between the survivors and the non-
survivors included ScvO2, PI and lactate at T8 after early
Table 1 Characteristics of the patients
Number of patients 202
Age, years 57 ± 18
Sex, n, female/male 104/98
Baseline PaO2, mmHg 142 ± 72







Postoperative with high risk 96
Other 22
Baseline APACHE II score 13 (9–20)
Baseline SOFA score 8 (5–10)
Baseline mechanical ventilation, % (n/total) 85 % (171/202)
Baseline NE, % (n/total) 37 % (75/202)
Baseline NE dose, ug/kg/min 0.11 ± 0.23
NE, % (n/total) at T8 48 % (96/202)
NE dose at T8, ug/kg/min 0.22 ± 0.63
ICU LOS, days 6 ± 10
Survivor/non-survivor at 30 days n/total (%) 28/202 (14 %)
Results are presented as mean ± SD or median (IQR) unless stated otherwise
Hb hemoglobin concentration, PaO2 arterial oxygen tension, APACHE acute
physiology and chronic health evaluation, SOFA sequential organ failure
assessment score, LOS length of stay, NE norepinephrine
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resuscitation. The AUC of the related variables used to
predict 30-day mortality are shown in Table 2. The ROC
curves of PI, lactate, ScvO2 and P(v-a)CO2 are shown in
Fig. 2. The PI at T8 was with the greatest AUC for predic-
tion of 30-day mortality and was significantly better than
ScvO2, P(v-a)CO2 and lactate. A PI threshold of 0.6 was
associated with a sensitivity of 60.71 % and a specificity of
89.66 % for predicting 30-day mortality.
Furthermore, there were 35 patients with PI ≤0.6 and
167 patients with PI >0.6 at T8 after resuscitation. There
were no differences in temperature, ScvO2, MAP or
CVP between patients with PI ≤0.6 and patients with
PI >0.6. Patients with PI ≤0.6 had higher lactate and
P(v-a)CO2 at T8 after resuscitation. The related data
are shown in Additional file 1.
Clinical classification based on ScvO2 (70 %) and critical
PI (0.6) at T8
According to the preset principle, the patients were assigned
to four categories: group 1 (PI ≤0.6 on ScvO2 < 70 %), group
2 (PI ≤0.6 on ScvO2 ≥ 70 %), group 3 (PI >0.6 on ScvO2
< 70 %), and group 4 (PI >0.6 on ScvO2 ≥ 70 %). Group 1
(low PI and low ScvO2) had the lowest survival rate at day
30 (log rank (Mantel–Cox) = 87.518, p <0.0001) (Fig. 3),
which was with the highest lactate level at T8 after resusci-
tation. The mortality at day 30 of groups are shown in the
Fig. 4, and group 2 (low PI and normal ScvO2) had the sec-
ond highest mortality. No differences in initial lactate levels
were observed between the four groups. Moreover, there
was no difference in lactate, PI or 30-day mortality between
Fig. 1 Flow diagram showing the 202 patients stratified according to central venous oxygen saturation (ScvO2) and peripheral perfusion index (PI)
at 8 h after resuscitation (T8). pts patients, T0 baseline
Table 2 Receiver operating characteristic (ROC) curve analysis of
the different variables at 8 h (T8) to predict mortality at 30 days
Variable ROC area 95 % CI Cutoff
value
Sensitivity Specificity
Lactate, mmol/L 0.693* 0.625, 0.756 3.6 35.71 94.83
ScvO2, % 0.669* 0.599, 0.733 70 42.86 83.33
P(v-a) CO2 0.596* 0.525, 0.664 6 42.86 70.11
PI 0.835 0.777, 0.884 0.6 60.71 89.66
P(v-a)CO2, difference between central venous and arterial PCO2 (mmHg),
PI peripheral perfusion index measured by pulse oximetry, ScvO2 central
venous O2 saturation
*P <0.05 for comparison of PI vs ScvO2, P(v-a) CO2, and lactate
Fig. 2 Receiver operating characteristic curves comparing the ability
of peripheral perfusion index (PI), lactate (Lac), difference between
central venous and arterial PCO2 (Pv-a CO2) and central venous O2
saturation (ScvO2) to discriminate mortality at day 30 in all the
critically ill patients. AUC area under the curve
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group 3 (normal PI and low ScvO2) and group 4 (normal
PI and normal ScvO2). The clinical characteristics of the
different groups are shown in Additional file 2.
In addition, patients were divided into three groups
according to the ScvO2 value at T8 after resuscitation
(low ScvO2 was defined as ScvO2 < 70 %, normal ScvO2
was defined as 70 % ≤ ScvO2 ≤ 80 %, high ScvO2 was de-
fined as ScvO2 > 80 %) (Table 3). The patients who had
low ScvO2 had a low PI, a high P(v-a)CO2 and high
mortality, and vice versa. Moreover, the patients with a
low PI (≤0.6) had low lactate clearance in sub-analysis of
the high ScvO2 group after resuscitation.
Multivariable logistic regression analysis
Multivariable logistic regression analysis at T8 demon-
strated that PI was an independent predictor of mortality
at day 30 (relative risk (RR) 2.439; 95 % CI 1.296-4.589,
P =0.006). When analysis was performed using the same
variables at T0, PI was not related to higher mortality at
day 30 (Table 4).
Relationship between PI and blood gas metabolic
parameters
The PI was significantly correlated with lactate (r =
−0.261, p <0.0001), P(v-a)CO2 (r = −0.152, p <0.0001),
and ScvO2 (r = 0.190, p <0.0001) in all of the mea-
surements (n = 404). In the sub-measurements of PI <1.4
(n = 204), these relationships seem to be slightly strength-
ened. However, in the sub-measurements of PI ≥1.4
(n = 200), these relationships were lacking (shown in
Additional file 3).
PI impairment stratification after normalized ScvO2
(≥70 %) at T8
After resuscitation, there were 167 patients with nor-
malized ScvO2 at T8. There were significant differ-
ences between survivors and non-survivors at day 30
in the time course of Pv-aCO2, lactate, and PI from
T0 to T8 during the resuscitation (repeated measure-
ments ANOVA, p <0.05) but not ScvO2.
Stratification by the severity of PI impairment was de-
fined as follows: normal PI (≥1.4), mild PI impairment
Fig. 3 Survival probabilities up to day 30 according to central
venous O2 saturation (ScvO2) and peripheral perfusion index (PI)
after 8 h of resuscitation. Log rank (Mantel–Cox) = 87.518, p <0.0001.
Group 1 (PI ≤0.6 with ScvO2 < 70 %); group 2 (PI ≤0.6 with ScvO2 ≥
70 %); group 3 (PI >0.6 with ScvO2 < 70 %); and group 4 (PI >0.6
with ScvO2≥ 70 %). Cum survival cumulative survival
Fig. 4 Mortality at day 30 for predefined groups based on PI(0.6) and ScvO2(70 %) at T8 after resuscitation. *p < 0.05. ns, no significance. group 1
(PI≤ 0.6 with ScvO2 < 70 %); group 2 (PI≤ 0.6 with ScvO2 ≥ 70 %); group 3 (PI > 0.6 with ScvO2 < 70 %); and group 4 (PI > 0.6 with ScvO2≥ 70 %)
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(0.6 < PI <1.4), and critical PI impairment (≤0.6). Accord-
ing to the classification of the severity of PI impairment at
T8, the clinical characteristics and outcome of patients
with different classifications of severity of impairment of
PI are shown in Table 5. The patients classified as having
critical PI impairment had higher lactate and APACHE II
scores and lower 8-h lactate clearance. However, there
was no difference between the patients with normal or
mild PI impairment in lactate at T8, 8-h lactate clearance
or the sequential organ failure assessment (SOFA) or
APACHE II scores.
Compared with patients with normal or mild PI im-
pairment, patients with critical PI impairment had the
greatest 30-day mortality (30-day mortality: normal PI vs
critical PI, 5/105 vs 9/25, χ2 = 19.459, p <0.0001; mild PI
vs critical PI, 9/25 vs 4/37, χ2 = 5.284, p = 0.029). How-
ever, there was no difference in 30-day mortality be-
tween the patients with normal or mild PI impairment
(30-day mortality: normal PI vs mild PI, 5/105 vs 4/37,
χ2 = 1.686, p = 0.24) (Fig. 5).
Discussion
To the best of our knowledge, this prospective, observa-
tional study is the largest reported to investigate the PI
prognostic value in critically ill patients. We showed the
following: (a) PI is an independent risk factor for 30-day
mortality, and a cutoff of PI <0.6 is related to poor out-
come following resuscitation; (b) after normalizing ScvO2
(≥70 %), patients with critical PI impairment (≤0.6) had
the worst outcome, but there was no difference in out-
come between patients with normal PI (≥1.4) and mild PI
impairment (0.6 < PI <1.4); and (c) the PI correlated with
lactate, P(v-a)CO2, and ScvO2. In addition, these relation-
ships seem to be strengthened with abnormal PI (PI <1.4)
but not with normal PI (PI ≥1.4).
It is well-known that persistent abnormalities in per-
ipheral perfusion are associated with a poor outcome
and multiple organ dysfunction, and regional tissue
perfusion variables are better than global variables for
predicting ICU mortality [18–24]. We also found the pa-
tients with poor PI (≤0.6) had higher lactate and worse
outcomes. Surprisingly, we found that the PI had the
greatest AUC for prediction of 30-day mortality after re-
suscitation, which was significantly better than lactate in
the mixed critically ill patients. We inferred that in the
heterogeneous patients there might be impairment of
the ability of lactate to predict the mortality, but the PI
still work. Additionally, we showed the PI at T8 is
related to the outcome, but not PI at T0. This was
consistent with the work of Poeze and colleagues. These
researchers also reported that gastric tonometry vari-
ables were predictive of outcome at the normalization of
global hemodynamics after resuscition, but not at the
initiation of resuscitation [23].
Table 3 Related variables and outcome of different groups
according to ScvO2 level at 8 h (T8) after resuscitation
Low
ScvO2 < 70 %
Normal
70 ≤ ScvO2 ≤ 80
High
ScvO2 > 80 %
n = 35 n = 90 n = 77
P(v-a) CO2 at T8 8 ± 4*
,** 6 ± 3** 5 ± 4
Lactate at T8, mmol/L 2.9 ± 3.8 1.9 ± 1.8 1.7 ± 1.7
8-h LC, % 13 (−3 to 50) 26 (1 to 50) 40 (1 to 57)
PI at T8 1.9 ± 1.7** 2.0 ± 1.3** 2.5 ± 1.6
Patients, n/total (%),
PI ≤0.6 at T8
10/35 (29 %) 15/90 (17 %) 10/77 (13 %)
Mortality at day 30,
n/total (%)
10/35 (29 %) 13/90 (14 %) 5/77 (6 %)
Results are presented as mean ± SD or median (IQR) unless stated otherwise
ScvO2 central venous oxygen saturation (%), P(v-a) CO2 veno-arterial CO2
tension difference (mmHg), PI peripheral perfusion index, LC lactate clearance
*P <0.05 for comparison to normal
**p <0.05 for comparison to high
Table 4 Multivariate logistic regression for predictors of 30-day mortality at baseline (T0) and 8 h (T8)
Variables T0 T8
RR 95 % CI P value RR 95 % CI P value
PI 1.055 0.685, 1.691 0.825 2.439 1.296, 4.589 0.006
Lactate 1.118 0.868, 1.439 0.388 1.228 0.886, 1.702 0.218
ScvO2,% 0.990 0.936, 1.046 0.710 1.080 1.007, 1.158 0.032
P(v-a)CO2, mmHg 0.981 0.866, 1.112 0.767 0.975 0.828, 1.148 0.763
HR 0.936 0.909, 0.965 0.000 0.964 0.939, 0.991 0.008
CVP 0.922 0.792, 1.074 0.298 1.059 0.890, 1.259 0.519
MAP 1.016 0. 983, 1.051 0.333 1.017 0.975, 1.060 0.434
Age, years 0.968 0.935, 1.002 0.068 0.998 0.967, 1.030 0.899
Gender 0.496 0.172, 1.434 0.196 0.396 0.128, 1.224 0.108
NE dose, ug/kg/min 0.146 0.022, 0.969 0.046 0.103 0.015, 0.692 0.019
CVP central venous pressure, MAP mean arterial pressure, HR heart rate, ScvO2 central venous oxygen saturation, P(v-a) CO2 difference in venoarterial CO2 tension,
NE norepinephrine, PI peripheral perfusion index
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The classification of severity of PI impairment
As we known, the classification of the severity of PI im-
pairment was first defined in critically ill patients. The
sacrifice of peripheral perfusion is a self-protection
mechanism in the critical condition, so the impairment
of PI might be acceptable to some extent. The peripheral
perfusion circulation is estimated in a binary fashion
(good or poor), which might be insufficient in clinical
practice.
To exclude the contribution of insufficient global oxy-
gen delivery (DO2) to low peripheral perfusion, we ana-
lyzed the classification of severity of PI impairment in
patients with normalized ScvO2 (≥70 %) after resuscita-
tion. We found that patients with a normal PI (>1.4) did
not have a better outcome than the patients with mild
PI impairment (0.6 − 1.4) after resuscitation. Therefore,
we speculated that pursuing total normalization of per-
ipheral perfusion might induce over-resuscitation but
might not improve the outcome after normal ScvO2 is
achieved. In other words, pursuing a better physiological
status is not necessarily associated with a better out-
come. We suggest that mild PI (0.6 − 1.4) impairment
might be “permissive impaired peripheral perfusion” and
does not call for immediate and aggressive resuscitation.
There is a wide variability in the course of individual re-
covery after optimization of DO2 in clinical practice, and
recently the indication for stopping resuscitation has
been emphasized [25]. Focus has been on the application
of a microvascular circulation perfusion indicator to
identify the endpoint during the resuscitation [26]. How-
ever, the greatest challenge of goal-directed micro-
circulation or local peripheral perfusion therapy is the
Table 5 Related variables and outcome in different groups
according to stratification by severity of impairment of PI at T8
after normalization of ScvO2 (≥70 %)
Critical Mild Normal
PI ≤0.6 0.6 < PI <1.4 PI ≥1.4
n = 25 n = 37 n = 105
T0 CVP, mmHg 9 ± 4 9 ± 3 10 ± 3
MAP 94 ± 20 90 ± 16 91 ± 17
ScvO2, % 71 ± 13 74 ± 11 77 ± 9
P(v-a) CO2, mmHg 8 ± 4** 6 ± 4 6 ± 3
Lactate, mmol/L 3.2 ± 3.1 2.6 ± 1.8 2.8 ± 2.2
PI 0.6 ± 0.6*,** 0.9 ± 0.6** 1.8 ± 1.3
T8 CVP, mmHg 9 ± 4 9 ± 3 8 ± 3
MAP 87 ± 15 88 ± 10 86 ± 13
ScvO2, % 80 ± 4 79 ± 6 80 ± 6
P(v-a) CO2, mmHg 7 ± 5 5 ± 3 5 ± 3
Lactate, mmol/L 2.9 ± 3.2** 1.8 ± 1.4 1.5 ± 1.2
PI 0.4 ± 0.2*,** 1 ± 0.2** 3.1 ± 1.2
Base APACHE II 20 (12 to 29)* 11 (8 to 21) 12 (7 to 16)
Base SOFA 9 (7 to 10)** 7 (5 to 11) 7 (4 to 9)
Mortality at day 30,
n/total (%)
9/25 (35 %)*,** 4/37 (11 %) 5/105 (5 %)
8-h LC, % 14 (−45 to 38)** 25 (−2.5 to 47) 43 (0 to 60)
Results are presented as mean ± SD or median (IQR) unless stated otherwise
APACHE acute physiology and chronic health evaluation, SOFA sequential
organ failure assessment score, CVP central venous pressure, MAP mean arterial
pressure, ScvO2 central venous oxygen saturation, P(v-a) CO2 veno-arterial CO2
tension difference, PI peripheral perfusion index, LC lactate clearance
*P <0.05 for comparison to mild-moderate
**p <0.05 compared to normal
Fig. 5 Mortality at day 30 according to stratification by severity of impairment of peripheral perfusion index (PI) after normalization of central
venous oxygen saturation (ScvO2) (≥70 %) at 8 h (T8). *P <0.05; ns not significant. PI ≥1.4 (normal PI, n = 105); 0.6 < PI <1.4 (PI mild impairment
n = 37); PI ≤0.6 (PI critical impairment, n = 25)
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definition of critical value. Animal and human studies
have showed that fluid therapy guided by local perfusion
parameters could reduce fluid administration and avoid
overtreatment, but not affect the outcome [27, 28]. The
critical value of PI defined in this paper needs further
interventional studies using peripheral perfusion as a
target for resuscitation.
The relevance of the combination of ScvO2 and PI
The concept of the relationship between DO2/VO2 was a
milestone in shock resuscitation, and determining the de-
pendence of DO2/VO2 is the core idea in managing shock
resuscitation [29–31]. The ScvO2 remains a simple indica-
tor of the global balance of DO2/VO2, although this idea
has been strongly challenged by others [2, 3, 32, 33]. In
our study, the percentage of patients with low ScvO2 was
small at T0, and it decreased significantly after early resus-
citation at T8 (T0 vs T8, 30 % vs 9 %). Beest et al. also
reported a relatively small incidence of low ScvO2 in crit-
ically ill patients on admission to the intensive care unit
[34]. The poor outcomes of patients with low ScvO2 have
largely been reported in various conditions. Therefore, it
is not surprising that persistently poor PI combined with a
low ScvO2 has been associated with the worst outcomes.
Our study supported the pursuit of normal ScvO2 as the
first goal in the case of persistently poor peripheral perfu-
sion (PI ≤0.6) after resuscitation.
Recently some studies have shown that high ScvO2 is
related to poor outcome [35–37]. However, our study
did not find that high ScvO2 is related to high mortality
after resuscitation in critically ill patients. We thought
the interpretation of high ScvO2 should be careful in
clinical practice. There are many factors that might con-
tribute to the high ScvO2, and the confounders of high
ScvO2 need to be better controlled in future studies
[38]. The present study was not powered to explore the
prognostic value of ScvO2 used as a marker of micro-
vascular shunting or oxygen extraction dysfunction.
Interestingly, we found a low PI was related to low lac-
tate clearance in the patients with high ScvO2 after re-
suscitation. The PI still worked in the patients with high
ScvO2. Therefore, the assessment of PI might be helpful
to identify mitochondrial and microcirculatory distress
syndrome in the patients with high ScvO2.
The relationship between PI and metabolic variables
Our study showed that the PI was significantly positively
correlated with ScvO2 and negatively correlated with lac-
tate and P(v-a)CO2 in all the 404 measurements. The
ScvO2, P(v-a)CO2, and lactate reflect the global DO2,
the global blood flow and anaerobic metabolism. Con-
versely, the PI reflects the local peripheral circulation
perfusion. Because the data were obtained in mixed crit-
ically ill patients, the correlation between PI and global
metabolic variables could be interpreted as consistency
between global and local variables caused by pooling the
data.
Intriguingly, the lactate levels correlated strongly with a
lower PI (PI <1.4) in the subset measurements. However,
the relationship was lacking for normal PI (PI ≥1.4). While
the presentation of normal PI might suggest sufficient per-
fusion, hyperlactatemia may not result from tissue hypo-
perfusion. Therefore, the relationship between lactate and
PI was weak for normal PI (PI ≥1.4). The interpretation of
hyperlactatemia in critically ill patients is complex,
and factors other than hypoperfusion may be involved
[39]. We inferred that peripheral circulation monitor-
ing could provide useful information to determine the
causes of hyperlactatemia (perfusion-related or non-
perfusion-related hyperlactatemia) in critically ill patients.
This hypothesis needs further research for clarification.
Limitations
Several limitations should be acknowledged. First, the
study period may be considered to be not long enough
to evaluate other relevant clinical outcomes, and the se-
lected time points are relatively arbitrary. Second, some
may argue that the patient population was heteroge-
neous, which may confound this study. However, all the
enrolled patients received a relative standard resuscita-
tion treatment because the new onset of suspected tissue
hypoperfusion occurred on the first day the patient was
admitted to the ICU. Therefore, the data were reason-
able and comparable. Third, the definition of tissue hy-
poperfusion might be limited and arbitrary. However,
the definition of tissue hypoperfusion was commonly
used in clinical practice in our study, which would always
trigger medical intervention. Therefore, the standard of
hypoperfusion could reflect a real clinical condition.
Fourth, some may argue that septic shock might be associ-
ated with peripheral vasodilation and local hyperperfusion,
which is known as “warm shock”. However, it is difficult
to use PI to define tissue hyper-perfusion (lack of com-
parison standard), and this has not been investigated.
Moreover, the roll of peripheral vasodilation and vasocon-
striction in sepsis is controversial [40]. As Gilbert first
noted that ‘dilation in one (vascular) bed might be ac-
companied by constriction elsewhere’ in 1960 [41], it is
well-known that the prominent feature of sepsis is a het-
erogeneous distribution of blood flow. Therefore, “local
tissue hyper-perfusion” might be tissue hypoperfusion but
not real hyperperfusion. Our previous study showed that
peripheral vasoconstriction can be a hallmark of early
septic shock [9, 10]. Furthermore, there may be a correl-
ation between peripheral vasoconstriction and unfavorable
outcome. How to restore the peripheral perfusion after
optimized global hemodynamic is controversial. Recently,
studies showed nitroglycerin could improve the PI but not
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improve the outcome [42, 43]. Fifth, we acknowledge our
failure to combine measurements with other peripheral
tissue perfusion indicators and clinical assessment (capil-
lary refill time/skin temperature/mottling score) in this
study. There are many noninvasive techniques available to
monitor peripheral circulation, and it is not yet clear
which one is the best to reflect a better outcome. Studies
also suggest that PI should always be used combined with
clinical assessment, and there are a many extra factors that
might impact the PI value [44, 45]. To reduce uncertainty
around these extra factors, we strictly controlled the con-
ditions (keeping a constant ambient temperature and
obtaining the PI value without movement, suction or
other extra stimulation). So, this limitation did not seem
to affect the conclusion. The variation in PI response to
the extra factors needs to be defined further in future
research.
Conclusion
PI is an independent risk factor for 30-day mortality fol-
lowing resuscitation. Successfully normalized PI (≥1.4)
during treatment might be an indication to stop the resus-
citation, whereas pursuing normalized PI (≥1.4) might not
result in better outcomes compared with mild-to-
moderate PI impairment after a normalized ScvO2. Com-
plementing ScvO2 assessment with PI during resuscitation
can better identify the endpoint of resuscitation and pa-
tients at higher risk of adverse outcomes.
Key messages
 PI is an independent risk factor for 30-day mortality,
and a cutoff of PI <0.6 is related to poor outcome
following resuscitation
 Pursuing a normalized PI (≥1.4) might not result in
better outcomes for mild PI impairment after
normalized of ScvO2
 The PI was correlated with lactate, P(v-a)CO2,
and ScvO2 in all of the measurements (n = 404).
These relationships seem to be strengthened with
abnormal PI (PI <1.4) but not with normal
PI (PI ≥1.4).
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